Body weight change associated kidney outcomes of sodium-glucose cotransporter new users.
Takahiro JimbaHidehiro KanekoTatsuhiko AzegamiYuta SuzukiAkira OkadaToshiyuki KoKatsuhito FujiuNorifumi TakedaHiroyuki MoritaKaori HayashiAkira NishiyamaKoichi NodeHideo YasunagaNorihiko TakedaMasaomi NangakuIssei KomuroPublished in: Diabetes, obesity & metabolism (2024)
Our analysis of a nationwide epidemiological cohort revealed that kidney outcomes following the initiation of SGLT2 inhibitors would be more favourable, with greater body weight loss observed after the initiation of SGLT2 inhibitors.